A Clinical Study on a Polyherbal Unani Formulation in the treatment of Chronic Gout (Hyperuricemia).

Therapeutic Evaluation of the Efficacy of a Polyherbal Unani Formulation in the form of Habb (Pill) in the Management of Niqris Muzmin (Chronic Gout-Hyperuricemia).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039544

Enrollment

Registered

2022-01-18

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: E798- Other disorders of purine and pyrimidine metabolism

Interventions

Intervention1: Habb (Pill) containing following Muffarad Advia (Single Unani Herbal Drugs)

Halela zard (Terminalia chebula), Turbud (Operculina turpethum), Babonaj (Matricaria chamomilla), Suranjan shireen (Colchicum autumnale), Bozidan (Pyrethrum indicum) and Namak Hindi (Salt).: The Polyh

Eligibility

Inclusion criteria

Inclusion criteria: Clinically/Radiologically diagnosed patients of Chronic Gout with Sr. Uric Acid Level > 7.2 mg/dL. 1. Patients with Joint Pain. 2. Patients with morning stiffness > 30 minutes. 3. Patients with joint swelling of the affected joint(s). 4. Patients with muscular weakness of the joint(s). 5. Patients with restricted movement of the joint(s).

Exclusion criteria

Exclusion criteria: 1. Any other disease or syndrome except Niqris. 2. Pregnant and Lactating women.

Design outcomes

Primary

Measure	Time frame
Relief in signs and symptoms of Chronic GoutTimepoint: 28 Days	—

Secondary

Measure	Time frame
Haematological, Radiological and Bio-Chemical assessment.Timepoint: 28 Days	—

Countries

India

Contacts

Public ContactDr Mohammed Sheeraz Mushtaque Ahmed

Regional Research Institute of Unani Medicine (RRIUM)

sheeraz.rrium@gmail.com9797750472

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026